Repository logo
 
Loading...
Thumbnail Image
Publication

Probiotics as an Alternative Therapy for Helicobacter pylori-Associated Diseases

Use this identifier to reference this record.
Name:Description:Size:Format: 
Helicobacter+pylori+Research.pdf10.67 MBAdobe PDF Download

Advisor(s)

Abstract(s)

Probiotics are live microorganisms which, when administered in adequate amounts, confer a health benefit to the host. Probiotics are not part of the current treatment therapies prescribed for Helicobacter pylori eradication, but there are numerous studies, most of them using probiotics as adjuvants to therapy, showing a reduction of side effects in the greater majority of cases. The probiotics administered vary hugely in the composition of microorganisms used, as well as the duration and mode of administration, which renders the comparison difficult. However, the most used probiotics for H. pylori infection are composed of Lactobacillus, Bifidobacterium, Saccharomyces, and Streptococcus. The mode of action of these probiotics relies on competition for nutrients and for adhesion to cell receptors, antimicrobial activity, and modulation of the immune system and microbiota.

Description

Keywords

Probiotics Helicobacter pylori Helicobacter pylori Infections Microbiota Lactobacillus Bifidobacterium Saccharomyces Streptococcus Infecções Gastrointestinais

Pedagogical Context

Citation

In: Backert S, Yamaoka Y (eds). Helicobacter pylori research : from bench to bedside. [Tokyo?]: Springer Japan, 2016, pp. 543-74. ISBN: 978-4-431-55934-4

Research Projects

Organizational Units

Journal Issue

Publisher

Springer Japan

CC License

Altmetrics